CEACAM5 and medullary thyroid gland carcinoma: Medullary thyroid carcinoma (MTC) requires pre-treatment assessment through serum calcitonin determination, carcinoembryonic antigen determination, genetic testing and other diagnostic criteria before the start of treatment.